Table 1.

Patient characteristics

	HCC (n = 37)
Sex (male/female)	25 / 12
Age (years)1	61.2 ± 3.2
Race (Caucasian/Asian/African)	32 / 2 / 3
Liver fibrosis (metavir score) F0 / F2 / F3 / F4‐cirrhosis	17 / 5 / 3 / 12
AFP (μg/L): <20 /20–400/ >400	26 / 3 / 8
Stage of disease (TNM)	St I n = 16, St II n = 16, St IIIa n = 3, St IVa n = 1, unknown 1

Abbreviations: AFP, alpha fetoprotein; TNM, tumor‐node‐metastasis.

Etiology of liver disease: no known liver disease (n = 14), HBV/HCV (n = 4/5), alcohol‐related liver disease (n = 4), HBV + alcohol (n = 1), non‐alcoholic steatohepatitis (NASH)/non‐alcoholic fatty liver disease (NAFLD) (n = 2/3), HBV + NASH (n = 1), Abernathy (n = 1), hemochromatosis (n = 2).

¹ Mean ± SEM.